Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Midlife metabolic factors and prostate cancer risk in later life.

Dickerman BA, Torfadottir JE, Valdimarsdottir UA, Wilson KM, Steingrimsdottir L, Aspelund T, Batista JL, Fall K, Giovannucci E, Sigurdardottir LG, Tryggvadottir L, Gudnason V, Markt SC, Mucci LA.

Int J Cancer. 2018 Mar 15;142(6):1166-1173. doi: 10.1002/ijc.31142. Epub 2017 Nov 16.

PMID:
29114858
2.

A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries.

Kjaer SK, Nygård M, Dillner J, Brooke Marshall J, Radley D, Li M, Munk C, Hansen BT, Sigurdardottir LG, Hortlund M, Tryggvadottir L, Joshi A, Das R, Saah AJ.

Clin Infect Dis. 2018 Jan 18;66(3):339-345. doi: 10.1093/cid/cix797.

PMID:
29029053
3.

Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.

Kjartansdottir OJ, Sigurdardottir LG, Olafsdottir EJ, Jonasson JG, Ursin G, Tryggvadottir L.

Breast Cancer Res Treat. 2017 Jun;163(2):363-373. doi: 10.1007/s10549-017-4171-2. Epub 2017 Mar 9.

PMID:
28281022
4.

Pineal Gland Volume Assessed by MRI and Its Correlation with 6-Sulfatoxymelatonin Levels among Older Men.

Sigurdardottir LG, Markt SC, Sigurdsson S, Aspelund T, Fall K, Schernhammer E, Rider JR, Launer L, Harris T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.

J Biol Rhythms. 2016 Oct;31(5):461-9. doi: 10.1177/0748730416656948. Epub 2016 Jul 22.

5.

Sleep Duration and Disruption and Prostate Cancer Risk: a 23-Year Prospective Study.

Markt SC, Flynn-Evans EE, Valdimarsdottir UA, Sigurdardottir LG, Tamimi RM, Batista JL, Haneuse S, Lockley SW, Stampfer M, Wilson KM, Czeisler CA, Rider JR, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):302-8. doi: 10.1158/1055-9965.EPI-14-1274. Epub 2015 Dec 16.

6.

Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.

Nygård M, Saah A, Munk C, Tryggvadottir L, Enerly E, Hortlund M, Sigurdardottir LG, Vuocolo S, Kjaer SK, Dillner J.

Clin Vaccine Immunol. 2015 Aug;22(8):943-8. doi: 10.1128/CVI.00133-15. Epub 2015 Jun 17.

7.

Circadian clock genes and risk of fatal prostate cancer.

Markt SC, Valdimarsdottir UA, Shui IM, Sigurdardottir LG, Rider JR, Tamimi RM, Batista JL, Haneuse S, Flynn-Evans E, Lockley SW, Czeisler CA, Stampfer MJ, Launer L, Harris T, Smith AV, Gudnason V, Lindstrom S, Kraft P, Mucci LA.

Cancer Causes Control. 2015 Jan;26(1):25-33. doi: 10.1007/s10552-014-0478-z. Epub 2014 Nov 12.

8.

Urinary melatonin levels, sleep disruption, and risk of prostate cancer in elderly men.

Sigurdardottir LG, Markt SC, Rider JR, Haneuse S, Fall K, Schernhammer ES, Tamimi RM, Flynn-Evans E, Batista JL, Launer L, Harris T, Aspelund T, Stampfer MJ, Gudnason V, Czeisler CA, Lockley SW, Valdimarsdottir UA, Mucci LA.

Eur Urol. 2015 Feb;67(2):191-4. doi: 10.1016/j.eururo.2014.07.008. Epub 2014 Aug 5.

9.

Sleep disruption among older men and risk of prostate cancer.

Sigurdardottir LG, Valdimarsdottir UA, Mucci LA, Fall K, Rider JR, Schernhammer E, Czeisler CA, Launer L, Harris T, Stampfer MJ, Gudnason V, Lockley SW.

Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):872-9. doi: 10.1158/1055-9965.EPI-12-1227-T.

10.

Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.

Sigurdardottir LG, Jonasson JG, Stefansdottir S, Jonsdottir A, Olafsdottir GH, Olafsdottir EJ, Tryggvadottir L.

Acta Oncol. 2012 Sep;51(7):880-9. doi: 10.3109/0284186X.2012.698751.

PMID:
22974093
11.

Circadian disruption, sleep loss, and prostate cancer risk: a systematic review of epidemiologic studies.

Sigurdardottir LG, Valdimarsdottir UA, Fall K, Rider JR, Lockley SW, Schernhammer E, Mucci LA.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1002-11. doi: 10.1158/1055-9965.EPI-12-0116. Epub 2012 May 7. Review.

Supplemental Content

Loading ...
Support Center